# OnCo record paper-aparicio-aggressive-variant-ccr-2013 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-aparicio-aggressive-variant-ccr-2013/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-aparicio-aggressive-variant-ccr-2013" ;
  schema:name "Platinum-based chemotherapy for variant castration-resistant prostate cancer (aggressive variant criteria)"@en ;
  schema:description "This trial defined clinical criteria for aggressive variant prostate cancer, such as visceral spread, low PSA relative to tumour burden and neuroendocrine features, and showed that these men respond to carboplatin-docetaxel followed by etoposide-cisplatin."@en ;
  schema:url <https://onco.cc/key-papers/paper-aparicio-aggressive-variant-ccr-2013/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1078-0432.CCR-12-3791>, <https://pubmed.ncbi.nlm.nih.gov/23649003/> ;
  schema:sameAs <https://doi.org/10.1158/1078-0432.CCR-12-3791> ;
  schema:datePublished "2013"^^xsd:gYear ;
  schema:author "Aparicio AM, Harzstark AL, Corn PG, et al." ;
  onco:cancers <https://onco.cc/cancers/prostate-nepc/> ;
  onco:journals <https://onco.cc/journals/clinical-cancer-research/> .